Biomerieux, Inc.

Hospices Civils De Lyon

Centre Hospitalier Universitaire De Nantes

Vygon

Bernard Allaouchiche

Guillaume Monneret

Fabienne Venet

Tanguy Fortin

Alexandre Pachot

Karim Asehnoune

Sylvie Pons

Marilyne Dupin

Antoine Roquilly

Audrey Larue-Triolet

Aurélie Gouel-Cheron

Benjamin Delcroix

Dominique Falcon

Rémi Bonidal

A method for predicting the risk of developing a disseminated infection in a patient admitted to intensive care having no clinical symptoms of such infection includes: determining a first dose of gelsolin G1 in a biological sample from the patient originating from a first sample taken at time T1, carried out between the day of intensive care admission and 48 hours afterward; determining a second dose of gelsolin G2 in a biological sample from the patient originating from a second sample taken at time T2, carried out two to three days after the first sampling; calculating the variation between the dose of gelsolin G2 and the dose of gelsolin G1, giving a &#x394; value; and comparing the &#x394; value to a threshold value S determined beforehand from two patient populations admitted to intensive care, one not having developed a disseminated infection and the other having developed such an infection.

Prediction of the risk of developing a disseminated infection for patients admitted to an intensive care unit

Growing community of inventors

Lyons, France

Bernard Allaouchiche